Article 1
Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2020/1093 of 24 July 2020 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 (Text with EEA relevance)
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
ANNEX The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows: The following Part D is added: βPART D Allocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 Active substance Rapporteur Member State Co-rapporteur Member State Alpha-cypermethrin FR AT Bacillus amyloliquefaciens subsp. plantarum strain D747 NL SK Bacillus amyloliquefaciens strain MBI 600 NL SK Beauveria bassiana strain NPP111B005 BE RO Beauveria bassiana strain 147 BE RO Bentazone PL EL Bordeaux mixture IT PL Chromafenozide CZ MT Copper hydroxide IT PL Copper oxide IT PL Copper oxychloride IT PL Cyantraniliprole ES FI Fenpicoxamid SE BG Flupyradifurone EL PL Gamma-cyhalothrin DE ES Halauxifen-methyl HU SE Isofetamid PT IE Mandestrobin SE NO Meptyldinocap HR DE Methoxyfenozide FR HU Metschnikowia fructicola strain NRRL Y-27328 NL HR Oxathiapiprolin NO CZ Pinoxaden FI BE Propyzamide DK DE Rescalure IE PT Sulfoxaflor AT ES Terpenoid blend QRD 460 FR DK Tribasic copper sulphate IT PLβ
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.